-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to a recent study, researchers from Ben Gurion University of the Negev (BGU) found that the Pfizer coronavirus vaccine is less effective against the South African variant, compared to the British variant and the original SARS-CoV- The neutralization ability of the two strains remained at a high level.
Their research was recently published in the "Cell Host Microbe" magazine.
The author of the article, Dr.
BGU scientists evaluated the effectiveness of the vaccine against the original virus strains, British and South African variants, and strains with changes in the peak binding of the virus.
Dr.
Source of information: Pfizer vaccine less effective against South African variant, study finds
Source of information: Pfizer vaccine less effective against South African variant, study findsOriginal source: Alona Kuzmina et al, SARS CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera, Cell Host & Microbe (2021).
Original source: Alona Kuzmina et al, SARS CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera, Cell Host & Microbe (2021).
